Global Multiple Sclerosis Therapeutics Market Growth (Status and Outlook) 2025-2031

October 2025 | 93 pages | ID: G8AE62F0D111EN
LP Information

Abstracts

According to this study, the global Multiple Sclerosis Therapeutics market size will reach US$ 19950 million by 2031.

Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problems between your brain and the rest of your body. Eventually, the disease can cause the nerves themselves to deteriorate or become permanently damaged.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the ?Multiple Sclerosis Therapeutics Industry Forecast? looks at past sales and reviews total world Multiple Sclerosis Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Multiple Sclerosis Therapeutics sales for 2025 through 2031. With Multiple Sclerosis Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Multiple Sclerosis Therapeutics industry.

This Insight Report provides a comprehensive analysis of the global Multiple Sclerosis Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Multiple Sclerosis Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Multiple Sclerosis Therapeutics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Multiple Sclerosis Therapeutics and breaks down the forecast by Type, by Distribution Channel, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Multiple Sclerosis Therapeutics.

This report presents a comprehensive overview, market shares, and growth opportunities of Multiple Sclerosis Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Beta Interferon
• Corticosteroids
• Monoclonal Antibodies
• Antineoplastic Agents
• Others

Segmentation by Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• e-Commerce

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Novartis
• Teva Pharmaceuticals
• Sanofi Genzyme
• Bayer
• Pfizer
• Biogen Idec
• Merck
• AbbVie

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Multiple Sclerosis Therapeutics Market Size (2020-2031)
  2.1.2 Multiple Sclerosis Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Multiple Sclerosis Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Multiple Sclerosis Therapeutics Segment by Type
  2.2.1 Beta Interferon
  2.2.2 Corticosteroids
  2.2.3 Monoclonal Antibodies
  2.2.4 Antineoplastic Agents
  2.2.5 Others
2.3 Multiple Sclerosis Therapeutics Market Size by Type
  2.3.1 Multiple Sclerosis Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Multiple Sclerosis Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Multiple Sclerosis Therapeutics Segment by Distribution Channel
  2.4.1 Hospital Pharmacies
  2.4.2 Retail Pharmacies
  2.4.3 e-Commerce
2.5 Multiple Sclerosis Therapeutics Market Size by Distribution Channel
  2.5.1 Multiple Sclerosis Therapeutics Market Size CAGR by Distribution Channel (2020 VS 2024 VS 2031)
  2.5.2 Global Multiple Sclerosis Therapeutics Market Size Market Share by Distribution Channel (2020-2025)

3 MULTIPLE SCLEROSIS THERAPEUTICS MARKET SIZE BY PLAYER

3.1 Multiple Sclerosis Therapeutics Market Size Market Share by Player
  3.1.1 Global Multiple Sclerosis Therapeutics Revenue by Player (2020-2025)
  3.1.2 Global Multiple Sclerosis Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Multiple Sclerosis Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 MULTIPLE SCLEROSIS THERAPEUTICS BY REGION

4.1 Multiple Sclerosis Therapeutics Market Size by Region (2020-2025)
4.2 Global Multiple Sclerosis Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Multiple Sclerosis Therapeutics Market Size Growth (2020-2025)
4.4 APAC Multiple Sclerosis Therapeutics Market Size Growth (2020-2025)
4.5 Europe Multiple Sclerosis Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Multiple Sclerosis Therapeutics Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Multiple Sclerosis Therapeutics Market Size by Country (2020-2025)
5.2 Americas Multiple Sclerosis Therapeutics Market Size by Type (2020-2025)
5.3 Americas Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Multiple Sclerosis Therapeutics Market Size by Region (2020-2025)
6.2 APAC Multiple Sclerosis Therapeutics Market Size by Type (2020-2025)
6.3 APAC Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Multiple Sclerosis Therapeutics Market Size by Country (2020-2025)
7.2 Europe Multiple Sclerosis Therapeutics Market Size by Type (2020-2025)
7.3 Europe Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Multiple Sclerosis Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL MULTIPLE SCLEROSIS THERAPEUTICS MARKET FORECAST

10.1 Global Multiple Sclerosis Therapeutics Forecast by Region (2026-2031)
  10.1.1 Global Multiple Sclerosis Therapeutics Forecast by Region (2026-2031)
  10.1.2 Americas Multiple Sclerosis Therapeutics Forecast
  10.1.3 APAC Multiple Sclerosis Therapeutics Forecast
  10.1.4 Europe Multiple Sclerosis Therapeutics Forecast
  10.1.5 Middle East & Africa Multiple Sclerosis Therapeutics Forecast
10.2 Americas Multiple Sclerosis Therapeutics Forecast by Country (2026-2031)
  10.2.1 United States Market Multiple Sclerosis Therapeutics Forecast
  10.2.2 Canada Market Multiple Sclerosis Therapeutics Forecast
  10.2.3 Mexico Market Multiple Sclerosis Therapeutics Forecast
  10.2.4 Brazil Market Multiple Sclerosis Therapeutics Forecast
10.3 APAC Multiple Sclerosis Therapeutics Forecast by Region (2026-2031)
  10.3.1 China Multiple Sclerosis Therapeutics Market Forecast
  10.3.2 Japan Market Multiple Sclerosis Therapeutics Forecast
  10.3.3 Korea Market Multiple Sclerosis Therapeutics Forecast
  10.3.4 Southeast Asia Market Multiple Sclerosis Therapeutics Forecast
  10.3.5 India Market Multiple Sclerosis Therapeutics Forecast
  10.3.6 Australia Market Multiple Sclerosis Therapeutics Forecast
10.4 Europe Multiple Sclerosis Therapeutics Forecast by Country (2026-2031)
  10.4.1 Germany Market Multiple Sclerosis Therapeutics Forecast
  10.4.2 France Market Multiple Sclerosis Therapeutics Forecast
  10.4.3 UK Market Multiple Sclerosis Therapeutics Forecast
  10.4.4 Italy Market Multiple Sclerosis Therapeutics Forecast
  10.4.5 Russia Market Multiple Sclerosis Therapeutics Forecast
10.5 Middle East & Africa Multiple Sclerosis Therapeutics Forecast by Region (2026-2031)
  10.5.1 Egypt Market Multiple Sclerosis Therapeutics Forecast
  10.5.2 South Africa Market Multiple Sclerosis Therapeutics Forecast
  10.5.3 Israel Market Multiple Sclerosis Therapeutics Forecast
  10.5.4 Turkey Market Multiple Sclerosis Therapeutics Forecast
10.6 Global Multiple Sclerosis Therapeutics Forecast by Type (2026-2031)
10.7 Global Multiple Sclerosis Therapeutics Forecast by Distribution Channel (2026-2031)
  10.7.1 GCC Countries Market Multiple Sclerosis Therapeutics Forecast

11 KEY PLAYERS ANALYSIS

11.1 Novartis
  11.1.1 Novartis Company Information
  11.1.2 Novartis Multiple Sclerosis Therapeutics Product Offered
  11.1.3 Novartis Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Novartis Main Business Overview
  11.1.5 Novartis Latest Developments
11.2 Teva Pharmaceuticals
  11.2.1 Teva Pharmaceuticals Company Information
  11.2.2 Teva Pharmaceuticals Multiple Sclerosis Therapeutics Product Offered
  11.2.3 Teva Pharmaceuticals Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Teva Pharmaceuticals Main Business Overview
  11.2.5 Teva Pharmaceuticals Latest Developments
11.3 Sanofi Genzyme
  11.3.1 Sanofi Genzyme Company Information
  11.3.2 Sanofi Genzyme Multiple Sclerosis Therapeutics Product Offered
  11.3.3 Sanofi Genzyme Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Sanofi Genzyme Main Business Overview
  11.3.5 Sanofi Genzyme Latest Developments
11.4 Bayer
  11.4.1 Bayer Company Information
  11.4.2 Bayer Multiple Sclerosis Therapeutics Product Offered
  11.4.3 Bayer Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Bayer Main Business Overview
  11.4.5 Bayer Latest Developments
11.5 Pfizer
  11.5.1 Pfizer Company Information
  11.5.2 Pfizer Multiple Sclerosis Therapeutics Product Offered
  11.5.3 Pfizer Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Pfizer Main Business Overview
  11.5.5 Pfizer Latest Developments
11.6 Biogen Idec
  11.6.1 Biogen Idec Company Information
  11.6.2 Biogen Idec Multiple Sclerosis Therapeutics Product Offered
  11.6.3 Biogen Idec Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Biogen Idec Main Business Overview
  11.6.5 Biogen Idec Latest Developments
11.7 Merck
  11.7.1 Merck Company Information
  11.7.2 Merck Multiple Sclerosis Therapeutics Product Offered
  11.7.3 Merck Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Merck Main Business Overview
  11.7.5 Merck Latest Developments
11.8 AbbVie
  11.8.1 AbbVie Company Information
  11.8.2 AbbVie Multiple Sclerosis Therapeutics Product Offered
  11.8.3 AbbVie Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 AbbVie Main Business Overview
  11.8.5 AbbVie Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Multiple Sclerosis Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Multiple Sclerosis Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Beta Interferon
Table 4. Major Players of Corticosteroids
Table 5. Major Players of Monoclonal Antibodies
Table 6. Major Players of Antineoplastic Agents
Table 7. Major Players of Others
Table 8. Multiple Sclerosis Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Multiple Sclerosis Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 10. Global Multiple Sclerosis Therapeutics Market Size Market Share by Type (2020-2025)
Table 11. Multiple Sclerosis Therapeutics Market Size CAGR by Distribution Channel (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2020-2025) & ($ millions)
Table 13. Global Multiple Sclerosis Therapeutics Market Size Market Share by Distribution Channel (2020-2025)
Table 14. Global Multiple Sclerosis Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Multiple Sclerosis Therapeutics Revenue Market Share by Player (2020-2025)
Table 16. Multiple Sclerosis Therapeutics Key Players Head office and Products Offered
Table 17. Multiple Sclerosis Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Multiple Sclerosis Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Multiple Sclerosis Therapeutics Market Size Market Share by Region (2020-2025)
Table 22. Global Multiple Sclerosis Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Multiple Sclerosis Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Multiple Sclerosis Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Multiple Sclerosis Therapeutics Market Size Market Share by Country (2020-2025)
Table 26. Americas Multiple Sclerosis Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 27. Americas Multiple Sclerosis Therapeutics Market Size Market Share by Type (2020-2025)
Table 28. Americas Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2020-2025) & ($ millions)
Table 29. Americas Multiple Sclerosis Therapeutics Market Size Market Share by Distribution Channel (2020-2025)
Table 30. APAC Multiple Sclerosis Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Multiple Sclerosis Therapeutics Market Size Market Share by Region (2020-2025)
Table 32. APAC Multiple Sclerosis Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 33. APAC Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2020-2025) & ($ millions)
Table 34. Europe Multiple Sclerosis Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Multiple Sclerosis Therapeutics Market Size Market Share by Country (2020-2025)
Table 36. Europe Multiple Sclerosis Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 37. Europe Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2020-2025) & ($ millions)
Table 38. Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 40. Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Multiple Sclerosis Therapeutics
Table 42. Key Market Challenges & Risks of Multiple Sclerosis Therapeutics
Table 43. Key Industry Trends of Multiple Sclerosis Therapeutics
Table 44. Global Multiple Sclerosis Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 45. Global Multiple Sclerosis Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 46. Global Multiple Sclerosis Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 47. Global Multiple Sclerosis Therapeutics Market Size Forecast by Distribution Channel (2026-2031) & ($ millions)
Table 48. Novartis Details, Company Type, Multiple Sclerosis Therapeutics Area Served and Its Competitors
Table 49. Novartis Multiple Sclerosis Therapeutics Product Offered
Table 50. Novartis Multiple Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. Novartis Main Business
Table 52. Novartis Latest Developments
Table 53. Teva Pharmaceuticals Details, Company Type, Multiple Sclerosis Therapeutics Area Served and Its Competitors
Table 54. Teva Pharmaceuticals Multiple Sclerosis Therapeutics Product Offered
Table 55. Teva Pharmaceuticals Multiple Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. Teva Pharmaceuticals Main Business
Table 57. Teva Pharmaceuticals Latest Developments
Table 58. Sanofi Genzyme Details, Company Type, Multiple Sclerosis Therapeutics Area Served and Its Competitors
Table 59. Sanofi Genzyme Multiple Sclerosis Therapeutics Product Offered
Table 60. Sanofi Genzyme Multiple Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. Sanofi Genzyme Main Business
Table 62. Sanofi Genzyme Latest Developments
Table 63. Bayer Details, Company Type, Multiple Sclerosis Therapeutics Area Served and Its Competitors
Table 64. Bayer Multiple Sclerosis Therapeutics Product Offered
Table 65. Bayer Multiple Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. Bayer Main Business
Table 67. Bayer Latest Developments
Table 68. Pfizer Details, Company Type, Multiple Sclerosis Therapeutics Area Served and Its Competitors
Table 69. Pfizer Multiple Sclerosis Therapeutics Product Offered
Table 70. Pfizer Multiple Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. Pfizer Main Business
Table 72. Pfizer Latest Developments
Table 73. Biogen Idec Details, Company Type, Multiple Sclerosis Therapeutics Area Served and Its Competitors
Table 74. Biogen Idec Multiple Sclerosis Therapeutics Product Offered
Table 75. Biogen Idec Multiple Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76. Biogen Idec Main Business
Table 77. Biogen Idec Latest Developments
Table 78. Merck Details, Company Type, Multiple Sclerosis Therapeutics Area Served and Its Competitors
Table 79. Merck Multiple Sclerosis Therapeutics Product Offered
Table 80. Merck Multiple Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 81. Merck Main Business
Table 82. Merck Latest Developments
Table 83. AbbVie Details, Company Type, Multiple Sclerosis Therapeutics Area Served and Its Competitors
Table 84. AbbVie Multiple Sclerosis Therapeutics Product Offered
Table 85. AbbVie Multiple Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 86. AbbVie Main Business
Table 87. AbbVie Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Multiple Sclerosis Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Multiple Sclerosis Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Multiple Sclerosis Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Multiple Sclerosis Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. Multiple Sclerosis Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Multiple Sclerosis Therapeutics Market Size Market Share by Type in 2024
Figure 10. Multiple Sclerosis Therapeutics in Hospital Pharmacies
Figure 11. Global Multiple Sclerosis Therapeutics Market: Hospital Pharmacies (2020-2025) & ($ millions)
Figure 12. Multiple Sclerosis Therapeutics in Retail Pharmacies
Figure 13. Global Multiple Sclerosis Therapeutics Market: Retail Pharmacies (2020-2025) & ($ millions)
Figure 14. Multiple Sclerosis Therapeutics in e-Commerce
Figure 15. Global Multiple Sclerosis Therapeutics Market: e-Commerce (2020-2025) & ($ millions)
Figure 16. Global Multiple Sclerosis Therapeutics Market Size Market Share by Distribution Channel in 2024
Figure 17. Global Multiple Sclerosis Therapeutics Revenue Market Share by Player in 2024
Figure 18. Global Multiple Sclerosis Therapeutics Market Size Market Share by Region (2020-2025)
Figure 19. Americas Multiple Sclerosis Therapeutics Market Size 2020-2025 ($ millions)
Figure 20. APAC Multiple Sclerosis Therapeutics Market Size 2020-2025 ($ millions)
Figure 21. Europe Multiple Sclerosis Therapeutics Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Multiple Sclerosis Therapeutics Market Size 2020-2025 ($ millions)
Figure 23. Americas Multiple Sclerosis Therapeutics Value Market Share by Country in 2024
Figure 24. United States Multiple Sclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Multiple Sclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Multiple Sclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Multiple Sclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Multiple Sclerosis Therapeutics Market Size Market Share by Region in 2024
Figure 29. APAC Multiple Sclerosis Therapeutics Market Size Market Share by Type (2020-2025)
Figure 30. APAC Multiple Sclerosis Therapeutics Market Size Market Share by Distribution Channel (2020-2025)
Figure 31. China Multiple Sclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Multiple Sclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Multiple Sclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Multiple Sclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. India Multiple Sclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Multiple Sclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Multiple Sclerosis Therapeutics Market Size Market Share by Country in 2024
Figure 38. Europe Multiple Sclerosis Therapeutics Market Size Market Share by Type (2020-2025)
Figure 39. Europe Multiple Sclerosis Therapeutics Market Size Market Share by Distribution Channel (2020-2025)
Figure 40. Germany Multiple Sclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 41. France Multiple Sclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Multiple Sclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Multiple Sclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Multiple Sclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Multiple Sclerosis Therapeutics Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Multiple Sclerosis Therapeutics Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Multiple Sclerosis Therapeutics Market Size Market Share by Distribution Channel (2020-2025)
Figure 48. Egypt Multiple Sclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Multiple Sclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Multiple Sclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Multiple Sclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Multiple Sclerosis Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Multiple Sclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 54. APAC Multiple Sclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 55. Europe Multiple Sclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Multiple Sclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 57. United States Multiple Sclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. Canada Multiple Sclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. Mexico Multiple Sclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Brazil Multiple Sclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. China Multiple Sclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Japan Multiple Sclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. Korea Multiple Sclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Multiple Sclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. India Multiple Sclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Australia Multiple Sclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. Germany Multiple Sclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. France Multiple Sclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. UK Multiple Sclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. Italy Multiple Sclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. Russia Multiple Sclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. Egypt Multiple Sclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. South Africa Multiple Sclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Israel Multiple Sclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. Turkey Multiple Sclerosis Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Global Multiple Sclerosis Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Multiple Sclerosis Therapeutics Market Size Market Share Forecast by Distribution Channel (2026-2031)
Figure 78. GCC Countries Multiple Sclerosis Therapeutics Market Size 2026-2031 ($ millions)